Filippatos, T D <br/><br/>
SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms.  [electronic resource] 

 -  Diabetes & metabolic syndrome   
 - 59-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1878-0334 
<br/><br/><label>Standard No.: </label>10.1016/j.dsx.2017.08.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzhydryl Compounds--therapeutic use<br/>Canagliflozin--therapeutic use<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Electrolytes--blood<br/>Glucosides--therapeutic use<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Metabolic Diseases--blood<br/>Sodium-Glucose Transporter 2<br/>Sodium-Glucose Transporter 2 Inhibitors